Back to Search
Start Over
Pharmacological evaluation of novel 5-HT3 receptor antagonist, QCM-13 (N-cyclohexyl-3- methoxyquinoxalin-2-carboxamide) as anti-anxiety agent in behavioral test battery.
- Source :
-
Journal of Pharmacy & Bioallied Sciences . Apr-Jun2015, Vol. 7 Issue 2, p103-108. 6p. - Publication Year :
- 2015
-
Abstract
- Objective: In the last few decades, serotonin type-3 (5-HT3) receptor antagonists have been identified as potential targets for anxiety disorders. In preclinical studies, 5-HT3 antagonists have shown promising antianxiety effects. In this study, a novel 5-HT3 receptor antagonist, QCM-13(N-cyclohexyl-3-methoxyquinoxalin-2-carboxamide) was evaluated for anxiolytic-like activity in rodent behavioral test battery. Materials and Methods: Mice were given QCM-13 (2 and 4 mg/kg, intraperitoneally [i.p.]) or diazepam (2 mg/kg, i.p.) or vehicle and after 30 min, mice were subjected to four validated behavioral test batteries viz. elevated plus maze, hole board, light-dark and open field tests. Interaction study of QCM-13 with m-chlorophenyl piperazine (mCPP) (mCPP, a 5-HT2A/2C receptor agonist, 1 mg/kg, i.p.) and buspirone (BUS, a partial 5-HT1A agonist, 10 mg/kg, i.p.) were performed to assess the pharmacological mechanism of the drug. Results: QCM-13 expressed potential anxiolytic effect with significant (P < 0.05) increase in behavioral parameters measured in aforementioned preliminary models. Besides, QCM-13 was unable to reverse the anxiogenic effect of mCPP, but potentiated anxiolytic affect of BUS. Conclusion: The results suggest that QCM-13 can be a potential therapeutic candidate for the management of anxiety-like disorders and combination doses of novel 5-HT3 receptor antagonist with standard anxiolytics may improve therapeutic efficacy. [ABSTRACT FROM AUTHOR]
- Subjects :
- *ANTIDEPRESSANTS
*PSYCHIATRIC drugs
*SEROTONIN
*LABORATORY mice
*ANXIETY
Subjects
Details
- Language :
- English
- ISSN :
- 09764879
- Volume :
- 7
- Issue :
- 2
- Database :
- Academic Search Index
- Journal :
- Journal of Pharmacy & Bioallied Sciences
- Publication Type :
- Academic Journal
- Accession number :
- 102050288
- Full Text :
- https://doi.org/10.4103/0975-7406.154429